Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

DEXAMETHASONE 4 MG TABLET

DEXAMETHASONE
$0.1921per EA

Strength

4 mg/1

Manufacturer

Advagen Pharma Ltd.

NDC

72888024001

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

DEXAMETHASONE

Approval Type

Generic (ANDA)

FDA Application

ANDA218372

On Market Since

10/15/2025

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price History

1W

0.0%

1M

-1.8%

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

-8.5%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

TRIAMCINOLONE 0.1% CREAM
Generic
00168000416•E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.
$0.0247
per GM
TRIAMCINOLONE 0.1% CREAM
Generic
16714098604•NorthStar Rx LLC
$0.0295
per GM
TRIAMCINOLONE 0.1% CREAM
Generic
21922006230•Encube Ethicals, Inc.
$0.0295
per GM
TRIAMCINOLONE 0.1% CREAM
Generic
33342032954•Macleods Pharmaceuticals Limited
$0.0295
per GM
TRIAMCINOLONE 0.1% CREAM
Generic
45802006405•Padagis Israel Pharmaceuticals Ltd
$0.0295
per GM
TRIAMCINOLONE 0.1% CREAM
Generic
52817081154•TruPharma LLC
$0.0295
per GM
TRIAMCINOLONE 0.1% CREAM
Generic
67877025145•Ascend Laboratories, LLC
$0.0295
per GM
DEXAMETHASONE 0.5 MG/5 ML LIQ
Generic
00054317763•Hikma Pharmaceuticals USA Inc.
$0.0297
per ML
TRIAMCINOLONE 0.1% CREAM
Generic
68462013159•Glenmark Pharmaceuticals Inc., USA
$0.0300
per GM
TRIAMCINOLONE 0.1% OINTMENT
Generic
16714027603•NorthStar Rx LLC
$0.0345
per GM

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy